The Efficacy and Safety of Maintenance With Doravirine Plus Two NRTIs After Initial Suppression in Adults With HIV-1 in the DRIVE-FORWARD Clinical Trial: Results From the Study Extension Through 192 Weeks

articulos_cientificos_2

Pedro Cahn, Jean-Michel Molina, Johan Lombaard, et al.

PIFELTRO (Doravirina)

Hidden
Hidden
Hidden
Este campo es un campo de validación y debe quedar sin cambios.

ES-DOV-00205